These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
953 related articles for article (PubMed ID: 16395838)
1. Patenting nanotechnology. Lemley MA Stanford Law Rev; 2005 Nov; 58(2):601-30. PubMed ID: 16395838 [TBL] [Abstract][Full Text] [Related]
2. Protecting new ideas and inventions in nanomedicine with patents. Bawa R; Bawa SR; Maebius SB; Flynn T; Wei C Nanomedicine; 2005 Jun; 1(2):150-8. PubMed ID: 17292072 [TBL] [Abstract][Full Text] [Related]
3. Patent first, ask questions later: morality and biotechnology in patent law. Bagley MA William Mary Law Rev; 2003 Dec; 45(2):469-547. PubMed ID: 15570677 [TBL] [Abstract][Full Text] [Related]
4. Patenting and licensing in genetic testing: recommendations of the European Society of Human Genetics. Aymé S; Matthijs G; Soini S; Eur J Hum Genet; 2008 May; 16 Suppl 1():S10-9. PubMed ID: 18432281 [TBL] [Abstract][Full Text] [Related]
5. Patenting and licensing of university-based genetic inventions--a view from experience at Stanford University's Office of Technology Licensing. Leute K Community Genet; 2005; 8(4):217-22. PubMed ID: 16244475 [TBL] [Abstract][Full Text] [Related]
6. Using the written description requirement to limit broad patent scope, allow competition, and encourage innovation in biotechnology. Mull WC Health Matrix Clevel; 2004; 14(2):393-435. PubMed ID: 15503695 [TBL] [Abstract][Full Text] [Related]
8. [Patents on life? No patent on life!]. van Raden L Dtsch Tierarztl Wochenschr; 1998 Mar; 105(3):90-3. PubMed ID: 9581373 [TBL] [Abstract][Full Text] [Related]
9. Patenting DNA. Bobrow M; Thomas S Curr Opin Mol Ther; 2002 Dec; 4(6):542-7. PubMed ID: 12596355 [TBL] [Abstract][Full Text] [Related]
10. [Intellectual property in natural sciences]. Twardowski T Postepy Biochem; 2008; 54(1):20-3. PubMed ID: 18610578 [TBL] [Abstract][Full Text] [Related]
11. Biotechnology patenting policy in the European Union--as exemplified by the development in Germany. Schrell A; Bauser H; Brunner H Adv Biochem Eng Biotechnol; 2007; 107():13-39. PubMed ID: 17522818 [TBL] [Abstract][Full Text] [Related]
12. Innovations and intellectual property: the case of genomic patenting. Jackson BA J Policy Anal Manage; 2003; 22(1):5-25. PubMed ID: 12722760 [TBL] [Abstract][Full Text] [Related]
14. ACOG Committee Opinion. Number 364 May 2007. Patents, medicine, and the interests of patients. Committees on Ethics and Genetics of American College of Obstetricians and Gynecologists Obstet Gynecol; 2007 May; 109(5):1249-54. PubMed ID: 17470613 [TBL] [Abstract][Full Text] [Related]
16. Patent border wars: defining the boundary between scientific discoveries and patentable inventions. Holman CM Trends Biotechnol; 2007 Dec; 25(12):539-43. PubMed ID: 17983675 [TBL] [Abstract][Full Text] [Related]
17. University-based science and biotechnology products: defining the boundaries of intellectual property. Kesselheim AS; Avorn J JAMA; 2005 Feb; 293(7):850-4. PubMed ID: 15713775 [TBL] [Abstract][Full Text] [Related]
18. Nanotechnology and Protection of Intellectual Property: Emerging Trends. Siri JGS; Fernando CAN; De Silva SNT Recent Pat Nanotechnol; 2020; 14(4):307-327. PubMed ID: 32532198 [TBL] [Abstract][Full Text] [Related]
19. Technology transfer at US universities: seeking public benefit from the results of basic research. Goodwin CD Technol Health Care; 1996 Sep; 4(3):323-30. PubMed ID: 8931243 [TBL] [Abstract][Full Text] [Related]
20. Patenting human pluripotent cells: balancing commercial, academic and ethical interests. Bahadur G; Morrison M Hum Reprod; 2010 Jan; 25(1):14-21. PubMed ID: 19897856 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]